# Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19

Study · id `cardio:ct-nct04936503` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04936503](<https://clinicaltrials.gov/study/NCT04936503>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04936503

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 984 participants.

## Technical summary

Registry record NCT04936503. Allocation not applicable; no masking; primary purpose prevention. Start 2020-06-18 (actual); primary completion 2021-03-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 984 participants (enrolled count; ClinicalTrials.gov record NCT04936503, source copy `cardio:ctgov-nct04936503-2021-06-23`, retrieved 2026-10-26)
- Started: 2020-06-18 (actual) (ClinicalTrials.gov record NCT04936503, source copy `cardio:ctgov-nct04936503-2021-06-23`, retrieved 2026-10-26)
- Primary completion: 2021-03-02 (actual) (ClinicalTrials.gov record NCT04936503, source copy `cardio:ctgov-nct04936503-2021-06-23`, retrieved 2026-10-26)
- Completion: 2021-03-02 (actual) (ClinicalTrials.gov record NCT04936503, source copy `cardio:ctgov-nct04936503-2021-06-23`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT04936503, source copy `cardio:ctgov-nct04936503-2021-06-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04936503-2021-06-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19
- Acronym: ASCCOVID19
- Condition: COVID-19
- Condition: Myocarditis
- Intervention (Diagnostic test): Resting electrocardiogram
- Intervention (Diagnostic test): Stress test
- Intervention (Diagnostic test): Cardiac echocardiography
- Intervention (Diagnostic test): Cardiac rhythm monitoring
- Intervention (Other): Questionnaire
- Intervention (Device): Injected Cardiac MRI
- Intervention (Biological): Blood sampling for biobank
- Lead sponsor: University Hospital, Bordeaux
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: University Hospital, Bordeaux (`cardio:org-university-hospital-bordeaux`)

## Provenance

Content hash: f91c852b6ad51d36a5e30ed1099a66282d202d5dc3722031b81b0259dad00300
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
